ciprofloxacin has been researched along with Clostridium Infections in 28 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Clostridium Infections: Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 9.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| "The fecal flora obtained from 13 patients with ulcerative colitis was examined at the beginning of a pouchitis episode before treatment, during treatment with metronidazole or ciprofloxacin, and during pouchitis-free periods." | 5.11 | Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. ( Gosselink, MP; Hop, WC; Laman, JD; Ruseler-van Embden, JG; Schouten, WR; van Lieshout, LM, 2004) |
| " sordellii ischio-rectal abscess with rapidly fatal septicaemia is described which complicated ultrasound-guided transrectal biopsy of the prostate, despite ciprofloxacin prophylaxis." | 3.70 | Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. ( Borer, A; Buskila, D; Gilad, J; Riesenberg, K; Schlaeffer, F; Sikuler, E, 1999) |
| "Many cases of Clostridioides difficile infection (CDI) are poorly responsive to standard antibiotic treatment strategies, and often patients suffer from recurrent infections characterized by severe diarrhea." | 1.51 | Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile. ( Allen-Vercoe, E; Carlucci, C; Carriero, C; Daigneault, M; Jones, CS; Oliphant, K; Petrof, EO; Robinson, A; Weese, JS; Yen, S, 2019) |
| "Fluoroquinolones increase the risk of Clostridioides difficile infection and antibiotic resistance." | 1.51 | The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study. ( Chopra, V; Conlon, A; Flanders, SA; Gandhi, T; Malani, AN; Vaughn, VM, 2019) |
| "The recent epidemic of Clostridium difficile infection (CDI) has been attributed largely to the REA strain group BI (aka NAP1/027)." | 1.37 | Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones. ( Gerding, DN; Johnson, S; Nagaro, K; Phillips, ST; Sambol, SP, 2011) |
| "No cases of Clostridium difficile infection were recorded for any of these patients within 1 month of receiving antibiotics." | 1.37 | Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections. ( Aliyu, SH; Doble, A; Madden, T; Neal, DE, 2011) |
| "Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada." | 1.35 | Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. ( Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M, 2008) |
| "Ciprofloxacin is an uncommon cause of pseudomembranous colitis." | 1.28 | Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody-positive patient. ( Harris, JR; Hillman, RJ; Rao, GG; Taylor-Robinson, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 15 (53.57) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Labbé, AC | 1 |
| Poirier, L | 1 |
| Maccannell, D | 1 |
| Louie, T | 1 |
| Savoie, M | 1 |
| Béliveau, C | 1 |
| Laverdière, M | 1 |
| Pépin, J | 1 |
| Jurburg, SD | 1 |
| Cornelissen, JJBWJ | 1 |
| de Boer, P | 1 |
| Smits, MA | 1 |
| Rebel, JMJ | 1 |
| Saint-Lu, N | 1 |
| Burdet, C | 1 |
| Sablier-Gallis, F | 1 |
| Corbel, T | 1 |
| Nevière, A | 1 |
| Sayah-Jeanne, S | 1 |
| Pulse, M | 1 |
| Weiss, W | 1 |
| Ferreira, S | 1 |
| Andremont, A | 1 |
| Mentré, F | 1 |
| de Gunzburg, J | 1 |
| Bohossian, HB | 1 |
| Lopes, EW | 1 |
| Roller, LA | 1 |
| Ananthakrishnan, AN | 1 |
| Zukerberg, LR | 1 |
| Cheng, JW | 1 |
| Liu, C | 2 |
| Kudinha, T | 1 |
| Xiao, M | 1 |
| Fan, X | 1 |
| Yang, CX | 1 |
| Wei, M | 1 |
| Liang, GW | 1 |
| Shao, DH | 1 |
| Xiong, ZJ | 1 |
| Hou, X | 1 |
| Yu, SY | 1 |
| Wang, Y | 1 |
| Yang, QW | 1 |
| Su, JR | 1 |
| Xu, YC | 1 |
| Baghani, A | 1 |
| Ghourchian, S | 1 |
| Aliramezani, A | 1 |
| Yaseri, M | 1 |
| Mesdaghinia, A | 1 |
| Douraghi, M | 1 |
| Carlucci, C | 1 |
| Jones, CS | 1 |
| Oliphant, K | 1 |
| Yen, S | 1 |
| Daigneault, M | 1 |
| Carriero, C | 1 |
| Robinson, A | 1 |
| Petrof, EO | 1 |
| Weese, JS | 1 |
| Allen-Vercoe, E | 1 |
| Vaughn, VM | 1 |
| Gandhi, T | 1 |
| Conlon, A | 1 |
| Chopra, V | 1 |
| Malani, AN | 1 |
| Flanders, SA | 1 |
| Babey, K | 1 |
| Kelton, S | 1 |
| Milne, WK | 1 |
| Muileboom, J | 1 |
| Voth, B | 1 |
| Kelly, L | 1 |
| Brintnell, WC | 1 |
| Dickins, T | 1 |
| Armitage, C | 1 |
| Zycinska, K | 1 |
| Chmielewska, M | 1 |
| Lenartowicz, B | 1 |
| Hadzik-Blaszczyk, M | 1 |
| Cieplak, M | 1 |
| Kur, Z | 1 |
| Krupa, R | 1 |
| Wardyn, KA | 1 |
| Nyc, O | 1 |
| Tejkalova, R | 1 |
| Kriz, Z | 1 |
| Ruzicka, F | 1 |
| Kubicek, L | 1 |
| Matejkova, J | 1 |
| Kuijper, E | 1 |
| Krutova, M | 1 |
| Tang, C | 1 |
| Cui, L | 1 |
| Xu, Y | 1 |
| Xie, L | 1 |
| Sun, P | 1 |
| Xia, W | 1 |
| Liu, G | 1 |
| Borgmann, S | 1 |
| Jakobiak, T | 1 |
| Gruber, H | 1 |
| Reil, M | 1 |
| Schroder, H | 1 |
| Kist, M | 1 |
| Sagel, U | 1 |
| Phillips, ST | 1 |
| Nagaro, K | 1 |
| Sambol, SP | 1 |
| Johnson, S | 1 |
| Gerding, DN | 2 |
| Madden, T | 1 |
| Doble, A | 1 |
| Aliyu, SH | 1 |
| Neal, DE | 1 |
| Popa, C | 1 |
| Wever, PC | 1 |
| Moviat, M | 1 |
| Meessen-Pinard, M | 1 |
| Sekulovic, O | 1 |
| Fortier, LC | 1 |
| Drekonja, DM | 1 |
| Rector, TS | 1 |
| Cutting, A | 1 |
| Johnson, JR | 1 |
| Thomas, C | 1 |
| Golledge, CL | 3 |
| Riley, TV | 3 |
| Gosselink, MP | 1 |
| Schouten, WR | 1 |
| van Lieshout, LM | 1 |
| Hop, WC | 1 |
| Laman, JD | 1 |
| Ruseler-van Embden, JG | 1 |
| Tekaya, R | 1 |
| Saidane, O | 1 |
| Abdelmoula, L | 1 |
| Ben Hadj Yahia, C | 1 |
| Manamani, L | 1 |
| Chaabouni, L | 1 |
| Zouari, R | 1 |
| Borer, A | 1 |
| Gilad, J | 1 |
| Sikuler, E | 1 |
| Riesenberg, K | 1 |
| Schlaeffer, F | 1 |
| Buskila, D | 1 |
| Carson, CF | 2 |
| O'Neill, GL | 1 |
| Bowman, RA | 2 |
| Moody, JA | 1 |
| Fasching, CE | 1 |
| Sinn, LM | 1 |
| Peterson, LR | 1 |
| Cain, DB | 1 |
| O'Connor, ME | 1 |
| Bates, CJ | 1 |
| Wilcox, MH | 1 |
| Spencer, RC | 1 |
| Harris, DM | 1 |
| Hillman, RJ | 1 |
| Rao, GG | 1 |
| Harris, JR | 1 |
| Taylor-Robinson, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis[NCT00583531] | Phase 2 | 2 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Lack of enrollment) | ||
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ciprofloxacin and Clostridium Infections
| Article | Year |
|---|---|
The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infe | 2016 |
1 trial available for ciprofloxacin and Clostridium Infections
| Article | Year |
|---|---|
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Clostridium perfringens; Coliti | 2004 |
26 other studies available for ciprofloxacin and Clostridium Infections
| Article | Year |
|---|---|
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acqu | 2008 |
Successional Dynamics in the Gut Microbiome Determine the Success of
Topics: Animals; Anti-Bacterial Agents; Bacterial Shedding; Ciprofloxacin; Clindamycin; Clostridioides diffi | 2019 |
DAV131A Protects Hamsters from Lethal
Topics: Administration, Oral; Adsorption; Animals; Anti-Bacterial Agents; Charcoal; Ciprofloxacin; Clostridi | 2019 |
Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clostridium Infections; Col | 2020 |
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides di | 2020 |
Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium I | 2018 |
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Clostridiales; Clostridi | 2019 |
The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Clostridium Infections; Cohor | 2019 |
Clostridium difficile infection in rural Ontario: a retrospective multisite population-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catchment Area, Health; Child; Ch | 2015 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; | 2016 |
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides dif | 2017 |
Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Contraindica | 2010 |
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; Clostridium | 2011 |
Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofl | 2011 |
H1N1 vaccination: expect the unexpected.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Clostridium Infections; Clostridium septicum; Female; Fl | 2011 |
Evidence of in vivo prophage induction during Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostr | 2012 |
Urinary tract infection in male veterans: treatment patterns and outcomes.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Clostridium Infections; Comorbidity; Drug Administration | 2013 |
Ciprofloxacin and Clostridium difficile--associated diarrhea.
Topics: Anti-Infective Agents; Australia; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; C | 2002 |
[Clostridium clostridiiforme vertebral osteomyelitis].
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clostridium; Clostridium Infections; Drug Therapy, Comb | 2008 |
Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy.
Topics: Abscess; Adenocarcinoma; Aged; Ampicillin; Anti-Infective Agents; Bacteremia; Biopsy; Ciprofloxacin; | 1999 |
Ciprofloxacin and Clostridium difficile-associated diarrhoea.
Topics: Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Humans; Microbial | 1992 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bac | 1990 |
Pseudomembranous colitis associated with ciprofloxacin.
Topics: Acute Disease; Aged; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Resistanc | 1990 |
Ciprofloxacin and Clostridium difficile infection.
Topics: Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Human | 1990 |
Ciprofloxacin and Clostridium difficile-associated diarrhoea.
Topics: Causality; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Culture Media; Cytotoxin | 1991 |
Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody-positive patient.
Topics: Adult; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Diarrhea; HIV Seropositivity | 1990 |